CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.

Chen, D;McKallip, RJ;Zeytun , A;Do, Y;Nagarkatti, M;et.al.
(2001) Journal of Immunology — Vol. 166, n° 10, p. 5889-97 (2001 May 15) (2001)

Files

No attached file found for this publication.

Details

Authors
  • Chen, DVirginia Commonwealth University, Medical College of Virginia Campus
    Author
  • McKallip, RJVirginia Commonwealth University, Medical College of Virginia Campus
    Author
  • Zeytun , AVirginia Commonwealth University, Medical College of Virginia Campus
    Author
  • Do, YVirginia Commonwealth University, Medical College of Virginia Campus
    Author
  • Nagarkatti, MVirginia Commonwealth University, Medical College of Virginia Campus
    Author
Show more
Affiliations
  • Virginia Commonwealth Univeristy, Medical College of Virginia CampusDepartments of Microbiologyy and Immunology & Pharmacology and Toxicology

Citations

Chen, D., McKallip, R., Zeytun, A., Do, Y., Lombard, C., Robertson, J., Mak, T., Nagarkatti, P., & Nagarkatti, M. (2001). CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. Journal of Immunology, 166(10), 5889-97 (2001 May 15). https://doi.org/10.4049/jimmunol.166.10.5889 (Original work published 2001)